Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lakshmi Rajdev
AIDS Malignancy Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Vincent'S Hospital
Darlinghurst, New South Wales, Australia
- University of New South Wales
Sydney, New South Wales, Australia
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Ucla Center for Clinical Aids Research and Education
Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Zuckerberg San Francisco General Hospital
San Francisco, California, United States
- George Washington University Medical Center
Washington D.C., District of Columbia, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Siteman Cancer Center at Washington University
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
- Memorial Sloan Kettering Commack
Commack, New York, United States
- Memorial Sloan Kettering Westchester
East White Plains, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital
The Bronx, New York, United States
- Memorial Sloan Kettering Nassau
Uniondale, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Temple University Hospital
Philadelphia, Pennsylvania, United States
- University of Pennsylvania/abramson Cancer Center
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Benaroya Research Institute at Virginia Mason
Seattle, Washington, United States
- Fhcc South Lake Union
Seattle, Washington, United States
- Harborview Medical Center
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Oct 2015
- Primary completion
- 1 May 2024
- Completion
- 31 Aug 2024
- Last update posted
- 21 Jan 2026
- Registered enrollment
- 79
- Registry id
- NCT02408861
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.